These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8302072)

  • 21. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged cardiac preservation. Evaluation of the University of Wisconsin preservation solution by comparison with the St. Thomas' Hospital cardioplegic solutions in the rat.
    Ledingham SJ; Katayama O; Lachno DR; Yacoub M
    Circulation; 1990 Nov; 82(5 Suppl):IV351-8. PubMed ID: 2225427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.
    Robinson LA; Harwood DL
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):314-25. PubMed ID: 1992242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart.
    Lawton JS; Sepic JD; Allen CT; Hsia PW; Damiano RJ
    Ann Thorac Surg; 1996 Jul; 62(1):31-8; discussion 38-9. PubMed ID: 8678673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardioplegia and vascular injury. Dissociation of the effects of ischemia from those of the cardioplegic solution.
    Saldanha C; Hearse DJ
    J Thorac Cardiovasc Surg; 1994 Aug; 108(2):279-90. PubMed ID: 8041176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of oxygenated St. Thomas' Hospital cardioplegic solution during ischaemic cardiac arrest: improved function, metabolism and ultrastructure.
    Choong YS; Cottier DS; Edgar SG
    J Cardiovasc Surg (Torino); 1993 Oct; 34(5):423-33. PubMed ID: 8282749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related effects of St Thomas' Hospital cardioplegic solution on isolated cardiomyocyte cell volume.
    Danetz JS; Clemo HF; Davies RD; Embrey RP; Damiano RJ; Baumgarten CM
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):467-76. PubMed ID: 10469961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superior qualities of University of Wisconsin solution for ex vivo preservation of the pig heart.
    Mankad PS; Severs NJ; Lachno DR; Rothery S; Yacoub MH
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):229-40. PubMed ID: 1495284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution.
    Ibrahim MF; Venn GE; Young CP; Chambers DJ
    Eur J Cardiothorac Surg; 1999 Jan; 15(1):75-83. PubMed ID: 10077377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional recovery of hearts after cardioplegia and storage in University of Wisconsin and in St. Thomas' Hospital solutions.
    Choong YS; Gavin JB
    J Heart Lung Transplant; 1991; 10(4):537-46. PubMed ID: 1911796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precursor trapping: a "neonatal" mechanism of myocardial protection.
    Olszanski DA; Ning XH; Childs KF; Bolling SF
    J Surg Res; 1993 Jun; 54(6):539-44. PubMed ID: 8412063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of immature myocardium by the addition of mannitol to crystalloid cardioplegic solution.
    Yang YJ
    J Formos Med Assoc; 1991 Jan; 90(1):24-30. PubMed ID: 1679105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and morphological changes in isolated rabbit hearts after prolonged hypothermic ischaemia: comparison of two cardioplegic solutions.
    Poltronieri R; Cevese A; Bregu R; Motta A; Zancanaro C; Bernocchi P
    Physiol Res; 1995; 44(3):157-64. PubMed ID: 8869272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
    Chambers DJ; Takahashi A; Hearse DJ
    J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation.
    Dobson GP; Jones MW
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):794-805. PubMed ID: 15001909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term preservation of explanted hearts perfused with L-aspartate-enriched cardioplegic solution. Improved function, metabolism, and ultrastructure.
    Choong YS; Gavin JB; Buckman J
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):210-8. PubMed ID: 1735986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial protection of neonatal heart by cardioplegic solution with recombinant human superoxide dismutase.
    Tatebe S; Nakazawa M; Miyamura H; Hayashi J; Eguchi S; Imai S
    Ann Thorac Surg; 1992 Jul; 54(1):124-9. PubMed ID: 1610223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-potassium University of Wisconsin solution for cardioplegia: improved protection of the isolated ischemic neonatal rabbit heart.
    Uesaka T; Chiba Y; Ihaya A; Nara M; Niwa H; Muraoka R
    Cardiovasc Surg; 1999 Dec; 7(7):723-9. PubMed ID: 10639047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of the chronic hypoxic immature rat heart during global ischemia.
    Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
    Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.